MA32800B1 - Solution a base d'uree format un film pour le traitement du psoriasis des ongles - Google Patents

Solution a base d'uree format un film pour le traitement du psoriasis des ongles

Info

Publication number
MA32800B1
MA32800B1 MA33852A MA33852A MA32800B1 MA 32800 B1 MA32800 B1 MA 32800B1 MA 33852 A MA33852 A MA 33852A MA 33852 A MA33852 A MA 33852A MA 32800 B1 MA32800 B1 MA 32800B1
Authority
MA
Morocco
Prior art keywords
film
urea
treatment
based solution
nail psoriasis
Prior art date
Application number
MA33852A
Other languages
Arabic (ar)
English (en)
French (fr)
Inventor
Sophie Chesnoy
Marlène DELAUNOIS
Héla Coubetergues
Pascal Lefrancois
Original Assignee
Fabre Pierre Dermo Cosmetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fabre Pierre Dermo Cosmetique filed Critical Fabre Pierre Dermo Cosmetique
Publication of MA32800B1 publication Critical patent/MA32800B1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/17Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015Drug-containing film-forming compositions, e.g. spray-on
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/12Keratolytics, e.g. wart or anti-corn preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
MA33852A 2008-10-21 2011-05-17 Solution a base d'uree format un film pour le traitement du psoriasis des ongles MA32800B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0857146A FR2937250B1 (fr) 2008-10-21 2008-10-21 Solution filmogene a base d'uree pour le traitement du psorasis de l'ongle
PCT/EP2009/063771 WO2010046375A1 (en) 2008-10-21 2009-10-21 Urea-based film-forming solution for treating nail psoriasis

Publications (1)

Publication Number Publication Date
MA32800B1 true MA32800B1 (fr) 2011-11-01

Family

ID=40823172

Family Applications (1)

Application Number Title Priority Date Filing Date
MA33852A MA32800B1 (fr) 2008-10-21 2011-05-17 Solution a base d'uree format un film pour le traitement du psoriasis des ongles

Country Status (23)

Country Link
US (1) US20110200544A1 (https=)
EP (1) EP2349243B1 (https=)
JP (1) JP2012506372A (https=)
KR (1) KR20110071118A (https=)
CN (1) CN102186468B (https=)
AR (1) AR074048A1 (https=)
AU (1) AU2009306462B2 (https=)
BR (1) BRPI0919833A2 (https=)
CA (1) CA2740001A1 (https=)
ES (1) ES2560178T3 (https=)
FR (1) FR2937250B1 (https=)
GE (1) GEP20135746B (https=)
IL (1) IL212372A0 (https=)
MA (1) MA32800B1 (https=)
MX (1) MX2011004016A (https=)
NZ (1) NZ592733A (https=)
PL (1) PL2349243T3 (https=)
PT (1) PT2349243E (https=)
RU (1) RU2508090C2 (https=)
TN (1) TN2011000167A1 (https=)
UA (1) UA102705C2 (https=)
WO (1) WO2010046375A1 (https=)
ZA (1) ZA201103437B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5840437B2 (ja) * 2011-09-30 2016-01-06 日本メナード化粧品株式会社 抗炎症剤
US20140271529A1 (en) * 2013-03-14 2014-09-18 Alc Therapeutics, Llc Antifungal compositions for the treatment of secondary skin and nail infections
CN104758273B (zh) * 2015-04-09 2018-04-20 山东罗欣药业集团股份有限公司 一种尿素微囊制剂及其制备方法
US20220249859A1 (en) * 2021-02-09 2022-08-11 Scholl's Wellness Company Llc Formulation and device for cosmetic treatment of onychomycosis
WO2026046372A1 (en) * 2024-08-30 2026-03-05 Shenzhen Pharmacin Co., Ltd. Compositions for nail conditions and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2613227B1 (fr) * 1987-04-01 1990-12-28 Oreal Compositions pharmaceutiques a base de nitrate de miconazole ou de nitrate d'econazole dans le traitement des infections fongiques des ongles
DE4212105A1 (de) * 1992-04-10 1993-10-14 Roehm Pharma Gmbh Nagellack zur Behandlung von Onychomykosen
RO118174B1 (ro) * 1997-08-21 2003-03-28 Aventis Pharma Deutschland Gmbh Lac de unghii şi utilizarea acestuia
ES2260093T3 (es) * 2000-01-03 2006-11-01 Karl Kraemer Preparados para la eliminacion ungueal atraumatica.
US7074392B1 (en) * 2000-03-27 2006-07-11 Taro Pharmaceutical Industries Limited Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections
US6281239B1 (en) * 2000-04-12 2001-08-28 Bradley Pharmeaceuticals, Inc. Method of treating onychomycosis
HUP0501023A3 (en) * 2001-01-09 2008-04-28 Dvoretzky Therapeutic film forming composition and treatment system therefor
DE10126501A1 (de) * 2001-05-30 2002-12-12 Aventis Pharma Gmbh Zubereitung zur Entfernung von abnormen Keratinmaterial
US6821508B2 (en) * 2001-06-27 2004-11-23 Rutgers, The State University Composition and method for topical nail treatment
CZ2004316A3 (cs) * 2001-09-04 2004-10-13 Trommsdorffágmbhá@Áco@Ákgáarzneimittel Náplast
US20040071760A1 (en) * 2002-01-07 2004-04-15 Israel Dvoretzky Therapeutic film forming composition and treatment system therefor
MXPA05002065A (es) * 2002-09-05 2005-06-08 Galderma Sa Solucion para aplicacion ungueal.
CN1215838C (zh) * 2003-06-25 2005-08-24 蚌埠丰原医药科技发展有限公司 双氯芬酸钠贴剂及其制备方法
EP1648378A2 (fr) * 2003-07-29 2006-04-26 Pierre Fabre Dermo-Cosmetique Vernis a ongles a action antimycosique
DE10341944A1 (de) * 2003-09-11 2005-04-28 York Pharma Plc Antimykotisch wirksame Nagellackformulierung mit substituierten 2-Aminothiazolen als Wirkstoff

Also Published As

Publication number Publication date
PT2349243E (pt) 2016-03-14
GEP20135746B (en) 2013-02-11
FR2937250B1 (fr) 2013-05-10
CN102186468B (zh) 2014-02-12
RU2508090C2 (ru) 2014-02-27
KR20110071118A (ko) 2011-06-28
BRPI0919833A2 (pt) 2015-12-15
FR2937250A1 (fr) 2010-04-23
HK1156532A1 (en) 2012-06-15
AU2009306462B2 (en) 2013-08-22
AR074048A1 (es) 2010-12-22
PL2349243T3 (pl) 2016-07-29
EP2349243B1 (en) 2015-11-11
AU2009306462A1 (en) 2010-04-29
TN2011000167A1 (en) 2012-12-17
RU2011119924A (ru) 2012-11-27
US20110200544A1 (en) 2011-08-18
CN102186468A (zh) 2011-09-14
NZ592733A (en) 2012-03-30
IL212372A0 (en) 2011-06-30
CA2740001A1 (en) 2010-04-29
WO2010046375A1 (en) 2010-04-29
MX2011004016A (es) 2011-05-19
EP2349243A1 (en) 2011-08-03
UA102705C2 (ru) 2013-08-12
ES2560178T3 (es) 2016-02-17
ZA201103437B (en) 2012-01-25
JP2012506372A (ja) 2012-03-15

Similar Documents

Publication Publication Date Title
MA32800B1 (fr) Solution a base d&#39;uree format un film pour le traitement du psoriasis des ongles
ATE440117T1 (de) Polymermicellen für die arzneistoffzufuhr
MA41294A (fr) Anticorps anti-myostatine, polypeptides contenant des variants de régions fc, et procédés d&#39;utilisation
EP3328541A4 (en) DIESEL OXIDATION CATALYST
EP3277698A4 (en) SI-CONTAINING FILM-FORMING COMPOSITIONS AND METHOD FOR USE THEREOF
MX369415B (es) Composiciones de limpieza personal concentradas.
EP2560653A4 (en) CERTAIN AMINO-PHYRIMIDINES, COMPOSITIONS AND METHOD FOR THEIR USE
MX2017013535A (es) Metodos y composiciones de limpieza personal concentradas.
EP2751135A4 (en) VEGF-SPECIFIC IMPORTERS, COMPOSITIONS AND METHOD FOR THEIR USE AND MANUFACTURE
EP2629799A4 (en) TOPICAL BASE AND ACTIVE COMPOSITIONS AND PROCESS FOR THE CARE AND TREATMENT OF THE SKIN
DK3793534T3 (da) Oral tablet til levering af aktive ingredienser til mavetarmkanalen
TN2014000195A1 (fr) 2-thiopyrimidinones
EP3322526A4 (en) IMPROVED COPPER-BASED MULTIMETAL CATALYSTS AND METHOD FOR THE PREPARATION THEREOF FOR THE PREPARATION OF BIOBASED 1,2-PROPANE DIOL
CY1118173T1 (el) 5-[(3,3,3-τριφθορο-2-υδροξυ-1-αρυλπροπυλ)αμινο]-1h-κινολιν-2-ονες, μια διεργασια για την παραγωγη τους και η χρηση τους ως αντι-φλεγμονωδων παραγοντων
EP3579888A4 (en) COMPOSITIONS FOR THE GENERATION OF ELECTROCHEMICAL AND METHODS OF USE THEREOF, AND WOUND PADS AND TREATMENT SYSTEMS THEREFORE
EP2542234A4 (en) PROCESS FOR USE OF (1S, 3S -) - 3-AMINO-4-DIFLUOROMETHYLENYL-1-CYCLOPENTANIC ACID
EP2721032A4 (en) POLYHEDRIC CAGE WITH METAL OPORPHYRENE EQUIPMENT, METHOD FOR THE PRODUCTION THEREOF AND METHOD FOR THEIR USE
EP2601951A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HEMORRH HORSES CAUSED BY BLOOD GRANULAR MATERIALS
EP3833366A4 (en) MIXTURES OF MICROORGANISMS, DERIVED MOLECULES THEREOF, AND METHODS OF USE THEREOF
EA201590475A1 (ru) Тетрациклиновые соединения
EP4370537A4 (en) Compositions including multi-agonist peptides and methods of manufacture and use
UY34543A (es) Derivados de sulfonilaminopirrolidinona, su preparación y aplicación terapéutica.
BR112019023830A2 (pt) processo para preparar metacroleína
MX382563B (es) Formas cristalinas de bilastina y procedimientos para su preparacion.
EP3672581A4 (en) AMANTADINE COMPOSITIONS, PREPARATIONS THEREOF AND METHOD OF USE